United Health's Q2的收益略微漏掉, 但收入增长了12.9%, 提高了2025年的利润指导。 UnitedHealth's Q2 earnings missed slightly, but revenue rose 12.9%, and it raised 2025 profit guidance.

联合保健小组报告,第二季度收入为每股4.08美元,略低于预期,收入为1116.2亿美元,比上一年增长12.9%。 UnitedHealth Group reported second-quarter earnings of $4.08 per share, slightly below expectations, on $111.62 billion in revenue, a 12.9% year-over-year increase. 股价为344.15美元,市场上限为3 116.9亿美元,P/E比率为14.91%,股息收益为2.6%。 The stock, trading at $344.15 with a market cap of $311.69 billion, has a P/E ratio of 14.91 and a 2.6% dividend yield. 尽管分析家有好坏参半的情绪,公司仍拥有“机动购买”共识评级和358.95美元平均价格目标。 Despite mixed analyst sentiment, the company holds a "Moderate Buy" consensus rating and a $358.95 average price target. United Health公司将其2025年EPS指南提高到16.00美元,而分析家预测收入会更高。 UnitedHealth raised its 2025 EPS guidance to $16.00, while analysts project higher earnings. 该公司通过四个部分运作:联合保健、Optum Health、Optum Insight和Optum Rx,提供保健福利、护理服务、数据分析以及全美国药店服务。 机构所有权仍然高达87.86%。 The firm operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx, providing health benefits, care delivery, data analytics, and pharmacy services across the U.S. Institutional ownership remains high at 87.86%.